Pharmabiz1h
Minghui Pharma to present phase I/II study results of MHB088C to treat patients with recurrent or metastatic solid tumors at ASCO meeting
Minghui Pharma to present phase I/II study results of MHB088C to treat patients with recurrent or metastatic solid tumors at ASCO meeting: Shanghai Friday, May 10, 2024, 18:00 Hrs ...
Pharmabiz2h
Andall Biosciences launches ovary care capsule, 23WELL
Shanghai Friday, May 10, 2024, 17:00 Hrs [IST] Andall Biosciences Inc (ABI), a renowned biotechnology company at the forefr ...
Pharmabiz3h
Acumen Pharma begins patient dosing in ALTITUDE-AD phase 2 trial of sabirnetug in early Alzheimer’s disease
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AßOs) for the treatment of Alzheimer’s ...
Pharmabiz4h
ENA Respiratory receives US patent covering INNA-051, a first-in-class antiviral innate immunomodulator
ENA Respiratory receives US patent covering INNA-051, a first-in-class antiviral innate immunomodulator: Melbourne, Australia Friday, May 10, 2024, 15:00 Hrs [IST] ENA Respiratory ...
Pharmabiz5h
US FDA grants breakthrough therapy designation to Avidity Biosciences’ delpacibart etedesiran to treat myotonic dystrophy type 1
US FDA grants breakthrough therapy designation to Avidity Biosciences’ delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Friday, May 10, 2024, 14:00 Hrs [IST] ...
Pharmabiz5h
OJSP launches Sudhamukti ayurvedic medicine for diabetes management
OJSP launches Sudhamukti ayurvedic medicine for diabetes management: Our Bureau, Mumbai Friday, May 10, 2024, 13:30 Hrs [IST] OJSP has launched Sudhamukti ayurvedic medicine, a br ...
Pharmabiz49m
Bayer to present results from phase III OASIS 1 and 2 of elinzanetant to treat vasomotor symptoms associated with menopause at ACOG meeting
Bayer will present detailed results from the pivotal phase III studies OASIS 1 and 2 evaluating the efficacy and safety of the investigational compound elinzanetant versus placebo, at the upcoming ...
Pharmabiz7h
Recce Pharma receives 2 patents in China for its RECCE 327 and RECCE 529 anti-infectives
Recce Pharmaceuticals Ltd, a company developing new class of synthetic anti-infectives designed to address the urgent global health problems of antibiotic-resistant superbugs and emerging viral ...
Pharmabiz5h
SEC recommends permission to SII for Omicron XBB 1.5 variant Covid-19 vaccine
A Subject Expert Committee (SEC), which advices the national drug regulator on approvals and clinical trials related to Covid-19 vaccines, has recommended grant of permission to Serum Institute of ...
Pharmabiz5h
As National Technology Day approaches, pharma MSMEs brace up to avail revamped PTUAS
Eves as the National Technology Day is approaching, the micro, small and medium enterprises (MSMEs) in the pharmaceutical industry are bracing up to avail the revamped Pharmaceutical Technology ...
Pharmabiz5h
ICMR releases application form for testing of vector control products
In a significant development aimed at enhancing public health initiatives, the Indian Council of Medical Research (ICMR) has unveiled an application form for the testing of vector control products.
Pharmabiz5h
PCI issues guidelines for institutions prior to commencement of inspection process
The Pharmacy Council of India (PCI) has issued guidelines for the institutions related to the inspection process for the academic year 2024-25, mandating that the students and the faculties should ...